John Markels
Director/Board Member presso SANGAMO THERAPEUTICS, INC.
Patrimonio netto: 31 077 $ in data 31/03/2024
Profilo
John H.
Markels is an Independent Director at Sangamo Therapeutics, Inc. He is also a Director at Arcturus Therapeutics, Inc., Arcturus Therapeutics Ltd., and Arcturus Therapeutics Holdings, Inc. Previously, he served as the President-Global Vaccines at Merck & Co., Inc. Dr. Markels holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of Delaware.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/06/2023 | 46 384 ( 0.02% ) | 31 077 $ | 31/03/2024 | |
| 15/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di John Markels
| Società | Posizione | Inizio |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director/Board Member | 11/02/2020 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Director/Board Member | 08/12/2022 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Precedenti posizioni note di John Markels
| Società | Posizione | Fine |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/03/2022 |
Formazione di John Markels
| University of California, Berkeley | Doctorate Degree |
| University of Delaware | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- John Markels
